S'abonner

Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer - 11/04/18

Doi : 10.1016/j.urology.2017.12.014 
Leilei Xia a, * , Benjamin L. Taylor a, Ronac Mamtani b, John P. Christodouleas c, Thomas J. Guzzo a
a Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 
b Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 
c Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 

*Address correspondence to: Leilei Xia, M.D., Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor 3400 Civic Center Boulevard, Philadelphia, PA 19104.Perelman Center for Advanced MedicineWest Pavilion, 3rd Floor 3400 Civic Center BoulevardPhiladelphiaPA19104

Abstract

Objective

To explore the associations between travel distance, hospital volume, and outcomes following radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC).

Method

The 2006 to 2013 National Cancer Database was queried to identify patients with MIBC who underwent RC. Multivariable regressions alternately including travel distance, hospital volume, and both in the models were used. Travel distances and hospital volumes were categorized by quartiles. Outcomes of interest were overall survival and quality-of-care indicators.

Result

A total of 6551 patients were included in the final cohort. When only travel distance or hospital volume was included in the multivariable regression model, fourth quartiles of both variables were associated with improved overall survival. When both travel distance and hospital volume were included in the model, only hospital volume was found to be associated with overall survival. Sensitivity analyses with both travel distance and hospital volume considered as continuous variables showed similar results. Patients who underwent RC in high-volume hospitals were more likely to receive neoadjuvant chemotherapy, have 10 or more lymph nodes removed, but also had higher odds of surgical delay (>3 months) in the full models adjusting for travel distance.

Conclusion

This National Cancer Database-based study suggests that the association between longer travel distance and improved overall survival (distance bias effect) after RC for MIBC is mainly mediated by higher hospital volume. The benefits of having RC at high-volume hospitals may outweigh the potential disadvantages of longer travel distance, which further supports the continued regionalization of RC and cancer care for MIBC.

Le texte complet de cet article est disponible en PDF.

Plan


 Financial Disclosure: The authors declare that they have no relevant financial interests.
 Disclaimer: The data used in this study are derived from a de-identified NCDB file. The American College of Surgeons and the Commission on Cancer have not verified and are not responsible for the analytic or statistical methodology employed, or the conclusions drawn from these data by the investigators.


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 114

P. 87-94 - avril 2018 Retour au numéro
Article précédent Article précédent
  • Impact of Cystectomy With Urinary Diversion Upon Tracked Receipt of Opioid Prescriptions Among Patients With Interstitial Cystitis/Bladder Pain Syndrome
  • David S. Koslov, Fernandino Vilson, Marc Colaco, Ryan P. Terlecki, Robert J. Evans
| Article suivant Article suivant
  • Promescent Has a Cytotoxic Impact on Fresh Human Sperm In Vitro
  • Melissa Sutton, Caitlin Hunn, Roxanne B. Summers-Colquitt, Shu-Hung Chen, Shahryar K. Kavoussi, Keikhosrow M. Kavoussi, Parviz K. Kavoussi

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.